OXALIPLATIN
Google image searchProduct monograph
Active ingredient
oxaliplatin, 5 MG/ML
DIN: 02444763
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 16-JAN-2019
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XA — Platinum compounds (ATC, ATC/DDD)
- L01XA03 — OXALIPLATIN (ATC/DDD)
Reference brand drug: Eloxatin
Pharmaceutical standard: MFR
